AAPL325.84+0.71 (+0.22%) ▲|ABBV259.84-0.15 (-0.06%) ▼|ABT111.32+2.39 (+2.19%) ▲|ACN187.12-0.97 (-0.52%) ▼|ADBE281.61-4.47 (-1.56%) ▼|AMAT438.54-3.31 (-0.75%) ▼|AMD456.87-2.74 (-0.60%) ▼|AMGN438.17+0.05 (+0.01%) ▲|AMT172.15-3.87 (-2.20%) ▼|AMZN254.77-0.15 (-0.06%) ▼|AVGO368.52-1.17 (-0.32%) ▼|AXP329.30+5.11 (+1.58%) ▲|BA209.56+3.90 (+1.90%) ▲|BAC62.38+0.39 (+0.62%) ▲|BKNG199.29+3.60 (+1.84%) ▲|BLK1,109.93-18.18 (-1.61%) ▼|BMY67.25+0.33 (+0.49%) ▲|BNY161.23+0.72 (+0.45%) ▲|BRK-B507.84+5.51 (+1.10%) ▲|C133.51+0.97 (+0.73%) ▲|CAT784.15+4.99 (+0.64%) ▲|CL90.72+1.09 (+1.22%) ▲|CMCSA27.13+0.83 (+3.14%) ▲|COF216.74+5.40 (+2.55%) ▲|COP136.78+0.59 (+0.43%) ▲|COST930.24-9.73 (-1.03%) ▼|CRM254.45-3.66 (-1.42%) ▼|CSCO108.89-0.86 (-0.78%) ▼|CVS98.11+0.51 (+0.52%) ▲|CVX211.96+0.91 (+0.43%) ▲|DE684.61+8.53 (+1.26%) ▲|DHR209.43+2.50 (+1.21%) ▲|DIS108.66+2.44 (+2.30%) ▲|DUK120.61+0.22 (+0.18%) ▲|EMR148.52+0.89 (+0.60%) ▲|FDX321.59-3.29 (-1.01%) ▼|GD364.09-5.33 (-1.44%) ▼|GE330.34-0.75 (-0.23%) ▼|GEV916.36+17.83 (+1.98%) ▲|GILD149.43-0.50 (-0.33%) ▼|GM84.73-0.91 (-1.06%) ▼|GOOG334.51+2.48 (+0.75%) ▲|GOOGL338.17+3.15 (+0.94%) ▲|GS999.83-2.73 (-0.27%) ▼|HD319.65-0.12 (-0.04%) ▼|HON206.60-3.38 (-1.61%) ▼|IBM232.47+1.07 (+0.46%) ▲|INTC90.12+1.15 (+1.29%) ▲|INTU342.80-2.13 (-0.62%) ▼|ISRG373.18+3.93 (+1.07%) ▲|JNJ274.76+3.57 (+1.32%) ▲|JPM354.69-0.26 (-0.07%) ▼|KO88.67+0.67 (+0.76%) ▲|LIN488.49+1.73 (+0.36%) ▲|LLY1,159.72-0.28 (-0.02%) ▼|LMT531.67-12.84 (-2.36%) ▼|LOW201.42+1.37 (+0.68%) ▲|LRCX287.81-2.39 (-0.82%) ▼|MA588.52+7.42 (+1.28%) ▲|MCD261.19+0.08 (+0.03%) ▲|MDLZ62.62+1.01 (+1.63%) ▲|MDT93.35+1.31 (+1.42%) ▲|META593.20+14.66 (+2.53%) ▲|MMM169.72-0.52 (-0.31%) ▼|MO69.77+0.20 (+0.29%) ▲|MRK150.66+0.80 (+0.53%) ▲|MS211.03-0.02 (-0.01%) ▼|MSFT496.11-4.91 (-0.98%) ▼|MU945.58+12.14 (+1.30%) ▲|NEE82.80-0.13 (-0.16%) ▼|NFLX82.17+1.36 (+1.68%) ▲|NKE38.39+0.27 (+0.71%) ▲|NOW137.32-5.58 (-3.90%) ▼|NVDA224.96+7.52 (+3.46%) ▲|ORCL144.73+3.41 (+2.41%) ▲|PEP141.13+1.34 (+0.96%) ▲|PFE28.87+0.32 (+1.12%) ▲|PG147.91+1.70 (+1.16%) ▲|PLTR168.02-11.90 (-6.61%) ▼|PM188.50+1.35 (+0.72%) ▲|QCOM169.10+2.49 (+1.49%) ▲|RTX200.99-4.18 (-2.04%) ▼|SBUX107.27+1.12 (+1.06%) ▲|SCHW108.55+0.27 (+0.24%) ▲|SO88.38+0.29 (+0.33%) ▲|SPG210.21-1.66 (-0.78%) ▼|T26.36+0.36 (+1.37%) ▲|TMO604.75+4.25 (+0.71%) ▲|TMUS187.17+5.01 (+2.75%) ▲|TSLA353.08-3.02 (-0.85%) ▼|TXN256.70+3.36 (+1.32%) ▲|UBER76.60+1.36 (+1.80%) ▲|UNH400.09+3.79 (+0.96%) ▲|UNP290.67+0.05 (+0.02%) ▲|UPS103.26+0.60 (+0.58%) ▲|USB62.60+1.39 (+2.26%) ▲|V379.26+6.59 (+1.77%) ▲|VZ50.69+0.39 (+0.77%) ▲|WFC89.67+2.63 (+3.02%) ▲|WMT106.05+0.13 (+0.12%) ▲|XOM163.07-1.49 (-0.90%) ▼|AAPL325.84+0.71 (+0.22%) ▲|ABBV259.84-0.15 (-0.06%) ▼|ABT111.32+2.39 (+2.19%) ▲|ACN187.12-0.97 (-0.52%) ▼|ADBE281.61-4.47 (-1.56%) ▼|AMAT438.54-3.31 (-0.75%) ▼|AMD456.87-2.74 (-0.60%) ▼|AMGN438.17+0.05 (+0.01%) ▲|AMT172.15-3.87 (-2.20%) ▼|AMZN254.77-0.15 (-0.06%) ▼|AVGO368.52-1.17 (-0.32%) ▼|AXP329.30+5.11 (+1.58%) ▲|BA209.56+3.90 (+1.90%) ▲|BAC62.38+0.39 (+0.62%) ▲|BKNG199.29+3.60 (+1.84%) ▲|BLK1,109.93-18.18 (-1.61%) ▼|BMY67.25+0.33 (+0.49%) ▲|BNY161.23+0.72 (+0.45%) ▲|BRK-B507.84+5.51 (+1.10%) ▲|C133.51+0.97 (+0.73%) ▲|CAT784.15+4.99 (+0.64%) ▲|CL90.72+1.09 (+1.22%) ▲|CMCSA27.13+0.83 (+3.14%) ▲|COF216.74+5.40 (+2.55%) ▲|COP136.78+0.59 (+0.43%) ▲|COST930.24-9.73 (-1.03%) ▼|CRM254.45-3.66 (-1.42%) ▼|CSCO108.89-0.86 (-0.78%) ▼|CVS98.11+0.51 (+0.52%) ▲|CVX211.96+0.91 (+0.43%) ▲|DE684.61+8.53 (+1.26%) ▲|DHR209.43+2.50 (+1.21%) ▲|DIS108.66+2.44 (+2.30%) ▲|DUK120.61+0.22 (+0.18%) ▲|EMR148.52+0.89 (+0.60%) ▲|FDX321.59-3.29 (-1.01%) ▼|GD364.09-5.33 (-1.44%) ▼|GE330.34-0.75 (-0.23%) ▼|GEV916.36+17.83 (+1.98%) ▲|GILD149.43-0.50 (-0.33%) ▼|GM84.73-0.91 (-1.06%) ▼|GOOG334.51+2.48 (+0.75%) ▲|GOOGL338.17+3.15 (+0.94%) ▲|GS999.83-2.73 (-0.27%) ▼|HD319.65-0.12 (-0.04%) ▼|HON206.60-3.38 (-1.61%) ▼|IBM232.47+1.07 (+0.46%) ▲|INTC90.12+1.15 (+1.29%) ▲|INTU342.80-2.13 (-0.62%) ▼|ISRG373.18+3.93 (+1.07%) ▲|JNJ274.76+3.57 (+1.32%) ▲|JPM354.69-0.26 (-0.07%) ▼|KO88.67+0.67 (+0.76%) ▲|LIN488.49+1.73 (+0.36%) ▲|LLY1,159.72-0.28 (-0.02%) ▼|LMT531.67-12.84 (-2.36%) ▼|LOW201.42+1.37 (+0.68%) ▲|LRCX287.81-2.39 (-0.82%) ▼|MA588.52+7.42 (+1.28%) ▲|MCD261.19+0.08 (+0.03%) ▲|MDLZ62.62+1.01 (+1.63%) ▲|MDT93.35+1.31 (+1.42%) ▲|META593.20+14.66 (+2.53%) ▲|MMM169.72-0.52 (-0.31%) ▼|MO69.77+0.20 (+0.29%) ▲|MRK150.66+0.80 (+0.53%) ▲|MS211.03-0.02 (-0.01%) ▼|MSFT496.11-4.91 (-0.98%) ▼|MU945.58+12.14 (+1.30%) ▲|NEE82.80-0.13 (-0.16%) ▼|NFLX82.17+1.36 (+1.68%) ▲|NKE38.39+0.27 (+0.71%) ▲|NOW137.32-5.58 (-3.90%) ▼|NVDA224.96+7.52 (+3.46%) ▲|ORCL144.73+3.41 (+2.41%) ▲|PEP141.13+1.34 (+0.96%) ▲|PFE28.87+0.32 (+1.12%) ▲|PG147.91+1.70 (+1.16%) ▲|PLTR168.02-11.90 (-6.61%) ▼|PM188.50+1.35 (+0.72%) ▲|QCOM169.10+2.49 (+1.49%) ▲|RTX200.99-4.18 (-2.04%) ▼|SBUX107.27+1.12 (+1.06%) ▲|SCHW108.55+0.27 (+0.24%) ▲|SO88.38+0.29 (+0.33%) ▲|SPG210.21-1.66 (-0.78%) ▼|T26.36+0.36 (+1.37%) ▲|TMO604.75+4.25 (+0.71%) ▲|TMUS187.17+5.01 (+2.75%) ▲|TSLA353.08-3.02 (-0.85%) ▼|TXN256.70+3.36 (+1.32%) ▲|UBER76.60+1.36 (+1.80%) ▲|UNH400.09+3.79 (+0.96%) ▲|UNP290.67+0.05 (+0.02%) ▲|UPS103.26+0.60 (+0.58%) ▲|USB62.60+1.39 (+2.26%) ▲|V379.26+6.59 (+1.77%) ▲|VZ50.69+0.39 (+0.77%) ▲|WFC89.67+2.63 (+3.02%) ▲|WMT106.05+0.13 (+0.12%) ▲|XOM163.07-1.49 (-0.90%) ▼|
21.3 C
New York
Wednesday, September 2, 2026

Tag: documents

newssourceFORcompanyinformationcontent1releasesmarket

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PicS N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PICS

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of PicS N.V. (NASDAQ: PICS) pursuant and/or traceable to PicS N.V.’s January 30, 2026 initial public offering (the “IPO”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2026.

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering

Persistent announces the intention to launch a voluntary public takeover offer for all outstanding Nagarro shares at EUR 81 per shareAll-cash offer represents a...

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "Decoy"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new...

2028 Investment Grade Bond Trust Launches At-The-Market Equity Program

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./TORONTO, June 26, 2026 /CNW/ - Next Edge Capital Corp. ("Next...

Texas Business Court Grants Neugebauer’s Motion for Expedited Discovery in Lawsuit filed by Fermi Seeking to Block Shareholder Accountability

After losing in federal court, Fermi Board pivots to Texas Business Court who grants Toby Neugebauer's motion for expedited discovery pertaining to Fermi Board's...

Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering

Cartesian Growth Corporation IV announced today the closing of its initial public offering of 27,500,000 units.

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis Approval includes a...

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.

Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChRa or anti-MuSKb antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.1,2 Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.3,4

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including...

THCA Flower for Sale: Exhale Wellness Expands Online Availability with New Exotic Indoor Strains for 2026

THCA flower for sale at Exhale Wellness: shop new exotic indoor-grown strains for 2026, lab-tested and Farm Bill-compliant. Buy premium hemp buds online.

E Fund (HK) HKEX Tech 100 Index ETF (3456) Lists Today

First ETF Tracking the HKEX Tech 100 Index – One-Click Access to Six Key Tech Innovation ThemesHONG KONG, June 26, 2026 /PRNewswire/ -- E Fund...

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /PRNewswire/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /CNW/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDocuments

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers